Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.67
-0.8600-4.64%
Post-market: 17.990.3186+1.80%19:30 EDT
Volume:3.47M
Turnover:61.92M
Market Cap:3.44B
PE:-35.29
High:18.63
Open:18.60
Low:17.52
Close:18.53
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.41
T/O Rate:3.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.79
PE(LYR):-10.91

Loading ...

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
13 hours ago

Legend Biotech Shares Down 1.8%; Co Appoints Ingrid Zhang as CEO

THOMSON REUTERS
·
Yesterday

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Yesterday

Legend Biotech Corporation - Alan Bash to Resume Role as President, Carvykti

THOMSON REUTERS
·
Yesterday

Legend Biotech Corporation - Appoints Ingrid Zhang as CEO Effective September 15, 2026

THOMSON REUTERS
·
Yesterday

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Dow Jones
·
Yesterday

Legend Biotech is Expected to Name Ingrid Zhang as Its New Chief Executive - WSJ

THOMSON REUTERS
·
Yesterday

Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline

TIPRANKS
·
Sep 14

Legend Biotech : Barclays Cuts Target Price to $74 from $78

THOMSON REUTERS
·
Sep 11

Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
Sep 11

U.S. Research Roundup- Adobe, Chewy, Mosaic

Reuters
·
Sep 11

RBC Capital Sticks to Its Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
Sep 11

GenScript Unit Legend Biotech to Present Updated Long-Term Carvykti Cartitude-2 Data at IMS Meeting

Reuters
·
Sep 10

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 04

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 01

Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?

Simply Wall St.
·
Aug 26

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Simply Wall St.
·
Aug 19

Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda

TIPRANKS
·
Aug 19

Legend Biotech Seeks Shareholder OK to Add 19.1 Million Shares to RSU Plan Reserve

Reuters
·
Aug 19

Legend Biotech Announces Annual General Meeting

Reuters
·
Aug 19